Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of Subanesthetic Concentrations of Nitrous Oxide - 1

This study has been completed.
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
University of Chicago Identifier:
First received: September 20, 1999
Last updated: May 26, 2015
Last verified: May 2015
The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To examine effects of subanesthetic concentrations of nitrous oxide on cold-pressor pain in humans.

Condition Intervention Phase
Opioid-Related Disorders
Substance-Related Disorders
Drug: 20% N2O
Drug: 30% N2O
Drug: 40% N2O
Phase 2

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
Official Title: Effects of Subanesthetic Concentrations of Nitrous Oxide

Resource links provided by NLM:

Further study details as provided by University of Chicago:

Primary Outcome Measures:
  • Pain intensity [ Time Frame: during cold test at 10 min & 30 min of inhalation ] [ Designated as safety issue: No ]
    Subjects immersed non-dominant arm for 3 minutes twice in 2-3 degree C water while inhaling 0 (placebo), 20, 30, or 40% N2O for a total of 40 minutes

Enrollment: 10
Study Start Date: September 1993
Study Completion Date: June 1995
Primary Completion Date: June 1995 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Control
Subject inhaled 0% N2O for 40 minutes with cold immersion at 10 and 30 minutes
Active Comparator: 20% N2O
Subject inhaled 20% N2O for 40 minutes with cold immersion at 10 & 30 minutes
Drug: 20% N2O
20% inhaled N2O
Active Comparator: 30% N2O
Subject inhaled 30% N2O for 40 minutes with cold immersion at 10 and 30 minutes
Drug: 30% N2O
30% inhaled N2O
Active Comparator: 40% N2O
Subject inhaled 40% N2O for 40 minutes with cold immersion at 10 and 30 minutes
Drug: 40% N2O
40% inhaled N2O


Ages Eligible for Study:   21 Years to 37 Years   (Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Please contact site for information.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00000249

United States, Illinois
University of Chicago, Anesthesia & Critical Care
Chicago, Illinois, United States, 60637
Sponsors and Collaborators
University of Chicago
National Institute on Drug Abuse (NIDA)
Principal Investigator: James Zacny, Ph.D. University of Chicago
  More Information

Pharmocol Biochem and Behavior 1995, 51( 2): 323-329

Responsible Party: University of Chicago Identifier: NCT00000249     History of Changes
Other Study ID Numbers: NIDA-08391-1  R01DA008391  R01-08391-1 
Study First Received: September 20, 1999
Last Updated: May 26, 2015
Health Authority: United States: Federal Government

Keywords provided by University of Chicago:
nitrous oxide
subjective effects
healthy volunteer

Additional relevant MeSH terms:
Opioid-Related Disorders
Substance-Related Disorders
Pathologic Processes
Chemically-Induced Disorders
Mental Disorders
Nitrous Oxide
Anesthetics, Inhalation
Anesthetics, General
Central Nervous System Depressants
Physiological Effects of Drugs
Analgesics, Non-Narcotic
Sensory System Agents
Peripheral Nervous System Agents processed this record on October 27, 2016